Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam
Leon J Nesti1, Wan-Ju Li, Rabie M Shanti
1Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Tissue Engineering. Part A
|August 19, 2008
Summary
Researchers developed a novel biomaterial construct using human mesenchymal stem cells (MSCs) to create a potential biological replacement for degenerated intervertebral discs (IVDs). This tissue-engineered approach offers a promising alternative to current treatments for debilitating disc degeneration.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Intervertebral disc (IVD) degeneration causes significant musculoskeletal disease and pain.
- Current treatments like spinal fusion compromise biomechanics, and prostheses have limitations.
- Biological approaches are crucial for effective IVD repair.
Purpose of the Study:
- To develop a biphasic tissue-engineered construct for IVD repair.
- To evaluate the chondrogenic potential of human mesenchymal stem cells (MSCs) within the construct.
- To create a scaffold mimicking native IVD architecture.
Main Methods:
- Seeding human MSCs onto a novel biphasic scaffold (hyaluronic acid hydrogel center, nanofibrous scaffold exterior).
- Inducing chondrogenesis in vitro using transforming growth factor-beta for 28 days.
- Analyzing construct development using histology, biochemistry, immunohistochemistry, and gene expression.
Main Results:
- The developed hyaluronic acid-nanofibrous scaffold (HANFS) construct mimicked native IVD structure (annulus fibrosus and nucleus pulposus regions).
- Seeded MSCs exhibited time-dependent chondrocytic differentiation and maintained IVD microarchitecture.
- Histological and molecular analyses confirmed the development of a cartilaginous phenotype.
Conclusions:
- MSC-seeded HANFS constructs show prototypic potential for biological IVD replacement.
- This approach offers a promising tissue engineering strategy for degenerated IVDs.
- Further development could lead to advanced biological treatments for disc disease.
